Genetic Medicines to Treat Cardiovascular Disease (A2)
January 25-28, 2027  | Keystone Resort, Keystone, CO, United States
Rick Dewey, Litsa G. Kranias and James S. Ware
Scholarship Deadline: Oct. 15, 2026 | Abstract Deadline: Jan. 5, 2027 | Early Registration Deadline: Nov. 25, 2026
* Session Chair † Invited but not yet accepted | Program current as of November 16, 2026 1 AM | For the most up-to-date details, visit https://www.keystonesymposia.org
Monday, January 25, 2027
4:00–8:00 PM Registration Longs Peak Foyer
6:00–8:00 PM Welcome Mixer Longs Peak Foyer
Tuesday, January 26, 2027
7:00–8:00 AM Breakfast Colorado Rockies Ballroom
8:00–8:10 AM Welcome Remarks Quandary Peak
8:10–9:00 AM Keynote Address Quandary Peak
  Sekar Kathiresan, Verve Therapeutics
The Human Genome as Teacher and Target: Two Decades of Genomic Discovery to Genomic Medicines
 
9:00–11:15 AM New Trailheads: Target Identification for Genetic Medicines in CV Disease Quandary Peak
  James S. Ware, Imperial College London
Large Scale Genomic Discovery of Causal Mechanisms in Heart Failure
 
  Victoria Parikh, Stanford University School of Medicine
Genotype-Phenotype Correlation in Inherited Cardiovascular Disease
 
  Rick Dewey, Versant Ventures
Target Selection for Genetic Medicines: Biobanks to Human Proof of Concept
 
  Tony Zeng, Stanford University
Short Talk: Perturb-seq in Endothelial Cells Identifies Key Regulators of Coronary Artery Disease States
 
9:30–9:50 AM Coffee Break Longs Peak Foyer
11:25–12:25 PM Panel Discussion 1: Development, Regulatory, Safety, and Ethical Considerations (including long-term and off-target effects of genetic medicines) Quandary Peak
  Rick Dewey, Versant Ventures
 
  Silvia G. Priori, Foundation Salvatore Maugeri
 
  Laura F. Michael, Eli Lilly and Company
 
12:25–1:00 PM Poster Setup Colorado Rockies Ballroom
12:25–2:30 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Colorado Rockies Ballroom
2:30–4:30 PM Symposia Spotlight 1: Emerging Biological Insights Driving the Next Generation of Genetics Medicines for CV Disease Quandary Peak
  Daniel Yang, University of Washington
Short Talk: Deep Mutational Scanning of MYH7 in Human Cardiomyocytes Enables High-Throughput Variant Interpretation
 
  Yensin Ang, Lexeo Therapeutics
Short Talk: From Mechanism to Clinic: A Unified and Differentiated AAV Strategy for Genetic Cardiomyopathies
 
  Areeba Iqbal †, University Of Agriculture, Faisalabad
Short Talk: - iPSC-Derived Cardiac Organoids for Personalized Cardiovascular Therapy Testing
 
  Yu-Chieh Chen, University of Connecticut Health Center
Short Talk: A Cellular Memory of Dilated Cardiomyopathy Limits Cardiac Plasticity After Genetic Correction and Is Overcome by Myofilament Calcium Sensitization
 
  Eren A Gunes, University of California, San Diego
Short Talk: Gene-Corrected HSPCs Restore LAMP2 Expression and Improve Survival in a Danon Disease Mouse Model
 
  Jesse Engreitz, Stanford University
Short Talk: Toward Genetic Medicines for Cardiovascular Diseases: Reprogramming Regulatory DNA with Prime Editing
 
  Tom Lumbers †, University College London
Short Talk: Understanding Heart Failure Risk and Progression Through Large-Scale Genomics
 
  Naoto Muraoka †, Gordian Biotechnology
Short Talk: Pooled In Vivo AAV Screening with Single-Nucleus Transcriptomic Readout Identifies Novel Genetic Medicines for HFpEF
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM Mechanisms and Models: From Variation to Validation Quandary Peak
  Cassady Rupert, Propria LLC
Modeling Human Cardiac Biology with Multi-Dimensional Engineered Human Heart Tissues
 
  Leslie A Leinwand, University of Colorado Boulder
Nature- Inspired Solutions to Common Metabolic Challenges
 
  Litsa G. Kranias, University of Cincinnati
Phospholamban Cardiomyopathy: From Bedside to Bench and Back
 
  Stephen Chang, Stanford University School of Medicine
Short Talk: A Primate Genetic Model Organism for Cardiovascular Disease
 
  Pablo Hofbauer, HeartBeat.bio AG
Short Talk: Harnessing Cardioids for Cardiomyopathy Gene Therapy: A High-Fidelity Disease Modeling and Screening Platform
 
7:00–8:00 PM Social Hour with Dinner Colorado Rockies Ballroom
7:30–10:00 PM Poster Session 1 Colorado Rockies Ballroom
Wednesday, January 27, 2027
7:00–8:00 AM Breakfast Colorado Rockies Ballroom
8:00–11:00 AM Gene Silencing in Cardiovascular Disease and Promising Avenues Quandary Peak
  Jiang Jianming, National University of Singapore
Talk Title to be Announced
 
  Stefanie Dimmeler, Institute of Cardiovascular Regeneration
Deciphering Noncoding RNAs in Cardiovascular Disease for RNA Therapeutics
 
  Euan A. Ashley, Stanford University
Allele-Specific Silencing in Cardiomyopathy
 
  Jin Billy Li, Stanford University
Endogenous RNA Editing in CV Disease: Mechanisms and Therapeutic Applications
 
  Annet N Linders †, PLaN Therapeutics
Short Talk: - Development of an Allele-Selective siRNA therapy for PLN-R14del Cardiomyopathy
 
  Elena Smekalova, Scribe therapeutics
Short Talk: Cas-X Based Investigational Gene Editor Targeting APOC3 Demonstrates Potent Editing in Non-Human Primates and Effectively Lowers Triglycerides in a Preclinical Model of Hypertriglyceridemia
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:00–1:00 PM Poster Setup Quandary Peak
11:00–3:30 PM On Own for Lunch
1:00–10:00 PM Poster Viewing Quandary Peak
3:30–4:30 PM Career Roundtable (Joint) Longs Peak
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–7:00 PM Therapeutic Gene Augmentation Strategies in CV Disease Quandary Peak
  Roger J Hajjar, Mass General Brigham
Engineering the Failing Heart: Innovations in Cardiac Gene Therapy
 
  Annemieke Aartsma-Rus, Leiden University Medical Center
Exon Skipping to Restore Gene Expression in Muscle Disease
 
  Farah Sheikh, University of California, San Diego
From Cell Junctional Failure to Gene Therapy in Arrhythmogenic Cardiomyopathy
 
  Timothy Calamaras †, Alexion, AstraZeneca Rare Disease
Short Talk: Development of an Optimized AAV Gene Therapy for MYBPC3 Associated Hypertrophic Cardiomyopathy
 
  Adam Helms, University of Michigan
Short Talk: Mapping and Rewiring the MYBPC3 Promoter for Rescue of Haploinsufficiency-Driven Hypertrophic Cardiomyopathy
 
7:00–8:00 PM Social Hour with Dinner Colorado Rockies Ballroom
7:30–10:00 PM Poster Session 2 Colorado Rockies Ballroom
Thursday, January 28, 2027
7:00–8:00 AM Breakfast Colorado Rockies Ballroom
8:00–11:00 AM Homing for Cures: Cardiomyocyte-Directed Delivery Approaches Quandary Peak
  Anastasia Khvorova, RNA Therapeutics Institute, UMass Chan Medical School
Novel Approaches for Oligonucleotide Delivery to Heart
 
  James Dahlman, Georgia Tech / Emory Medical School
Lipid Nanoparticles: Past, Present, and Future of RNA Delivery
 
  Husam Younis, Atrium Therapeutics, Inc.
siRNA Delivery to the Heart: Opportunities in Genetic Cardiomyopathy
 
  Georgios Karamanlidis, Atrium Therapeutics
Short Talk: ATR 1086 Prevents Heart Failure and Rescues Survival in a Mouse Model of PLN-R14del Cardiomyopathy
 
  Yunxi Chen, University of Southern California
Short Talk: Engineering MicroRNA-Enriched Extracellular Vesicles to Inhibit Atherosclerotic Plaque Growth and Vascular Calcification
 
9:00–9:20 AM Coffee Break Longs Peak Foyer
11:10–12:10 PM Panel Discussion 2: Navigating the Valley of Opportunity: Moving Ideas from Idea to Products for Patients with Academia, Venture Capital, and Pharma Quandary Peak
  Sekar Kathiresan, Verve Therapeutics
 
  Roger J Hajjar, Mass General Brigham
 
12:10–2:30 PM On Own for Lunch
2:30–4:30 PM Symposia Spotlight 2: Emerging Translational Strategies in CV Disease Quandary Peak
  Mena F Abdelsayed, Lankenau Institute for Medical Research
Short Talk: Alternans in PLN R14del Cardiomyocytes Differs Between Two Isogenic Pairs of Different Origin
 
  Andreas M. Zeiher †, University Frankfurt
Short Talk: Hepatic microRNA-92a Inhibition Attenuates Liver Injury and Reduces Cardiac Fibrotic Remodeling in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
 
  Jeffrey D Steimle, Cincinnati Children's Medical Hospital Center
Short Talk: PITX2 Missense Coding Variant Expression Reveals Direct Function in Atrial Fibrillation
 
  Ze Cheng †, Tenaya Therapeutics
Short Talk: In Vivo Rescue of Cardiomyopathy Through Cardiac Prime Editing
 
  Michael S Kapiloff, Stanford University
Short Talk: Targeting of Perinuclear β1-Adrenergic Receptors Inhibits Pathological Cardiac Remodeling
 
  Tianyu Wu, Duke University
Short Talk: Engineered BacNav Platform for Precision Cardiac Gene Therapies
 
  Brad A. Amendt, University of Iowa
Short Talk: RNA Technology to Regenerate a Myocardial Infarct Through Re-Activation of a Developmental Gene Network
 
  Gabriella Kabboul, Brigham and Women's Hospital & Harvard Medical School
Short Talk: Circular RNA-Mediated CCN5 Expression Reverses Pathologic Cardiac Remodeling and Improves Cardiac Function After Myocardial Infarction
 
4:30–5:00 PM Coffee Available Longs Peak Foyer
5:00–6:15 PM Products to Patients: Therapeutic Development and Trial Design Quandary Peak
  Laura F. Michael, Eli Lilly and Company
Lp(a) - From Genetic Insight to Novel Biology and Breakthrough Therapy
 
  Silvia G. Priori, Foundation Salvatore Maugeri
Therapeutic Development of Genetic Medicines for Arrhythmogenic Cardiovascular Disease
 
  Eileen Blasi, Atrium Therapeutics
Short Talk: ATR 1072 Prevents Cardiac Glycogen Accumulation and Hypertrophy in a Preclinical Model of PRKAG2 Syndrome
 
6:15–7:05 PM Closing Keynote Address Quandary Peak
  Christine E. Seidman, Harvard Medical School
Modeling Cardiovascular Disease: Genetics, Cellular Systems, Human Models
 
7:05–7:15 PM Meeting Wrap-Up: Outcomes and Future Directions Quandary Peak
7:15–8:15 PM Social Hour with Dinner Colorado Rockies Ballroom
8:00–9:00 PM Entertainment Colorado Rockies Ballroom
8:00–9:00 PM Cash Bar Colorado Rockies Ballroom
Friday, January 29, 2027
12:00–11:59 PM Departure